Memorial Hospital Research Laboratories

The Andrew Jackson Lab

Research

Pictured: Andrew Jackson
Andrew Jackson, PhD

I am an associate attending medical physicist in the Computer Service of the Department of Medical Physics. Throughout my career, I have focused on the use of computer optimization to strike a balance between achieving local tumor control with therapeutically effective doses of radiation and minimizing damage to surrounding healthy tissue. To this end, I create software to optimize and evaluate treatment plans for external beam radiation therapy. I also work in the Predictive Informatics Service, studying the relationship between treatment outcome and the amount of radiation received by a tumor and normal tissue during radiotherapy for prostate, lung, head and neck, and paraspinal cancers.

View Lab Overview

People

Pictured: Andrew Jackson

Andrew Jackson, PhD

  • Medical physicist Andrew Jackson studies the relationship between radiotherapy dose distributions and treatment outcome and the optimization of radiotherapy treatment planning.
212-639-7685
Office Phone
Lab Affilations

Get in Touch

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Andrew Jackson discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures